Summary: A large genomic study shows that parental age, ancestry and parental smoking each leave subtle but measurable effects on the number and types of de novo germline mutations (DNMs) children inherit. By analysing whole genomes from about 10,000 parent–child trios, researchers found that most variation in mutation counts is explained by parental age—particularly the father’s—but small consistent differences are associated with genetic ancestry and with a parental history of smoking.
This research challenges the long-standing assumption that germline mutation rates are uniform across populations and environments, and it provides new context for population genetics and clinical studies that model mutation rates.
Key findings
- Parental age is the dominant factor: Each additional year of paternal age contributes roughly 1.5 extra DNMs while each additional year of maternal age contributes about 0.4.
- Ancestry differences: Individuals of African ancestry showed a slightly higher average number of DNMs (around 67 per generation) than European, American and South Asian groups (around 64), a difference roughly equivalent to a father being two years older.
- Smoking association: A documented history of parental smoking was linked to a small but statistically significant increase in DNM counts—an increase on the order of 2% on average, equivalent to less than one extra DNM per smoking parent over a reproductive lifetime.
Published in Nature Communications, the study was carried out by teams at the Wellcome Sanger Institute, the University of Cambridge and collaborators using data from the 100,000 Genomes Project. The authors identified nearly 690,000 de novo variants by comparing each child’s genome to those of their parents and cataloguing mutations present in the child but absent in both parents.
Germline mutation rate matters because most DNMs are neutral or mildly harmful, while a small fraction can cause serious genetic conditions. Evolution and cellular mechanisms keep germline mutation rates low to preserve genome integrity, but they are not absolute: some variation remains and this study begins to quantify what contributes to that variation.
The analysis shows that although age—particularly paternal age—explains the largest share of variability in mutation counts, ancestry and environmental exposures account for a measurable portion as well. The observed ancestry differences may reflect population-specific genetic factors, environmental exposures that vary by region or population, or a combination of both. The study did not find evidence that common genetic variants within people of European ancestry drive DNM rate variation, though average genetic differences between ancestry groups could still play a role.
The link with smoking was modest but statistically robust: children whose parents had documented smoking histories in health records carried a slightly higher number of DNMs than those whose parents were recorded as non-smokers. The researchers underline that the association does not prove causation—smoking could be a marker for other exposures or lifestyle factors that influence mutation processes.
Beyond its immediate results, the study has implications for how researchers model mutation processes in population genetics, evolutionary biology and medical genetics. Many current analyses assume uniform mutation rates across populations and environments; incorporating modest ancestry- and exposure-associated differences might improve power and accuracy when reconstructing population history or searching for genes involved in rare disorders using de novo variants.
Co-senior authors noted that the scale and diversity of the dataset made these discoveries possible. Dr Aylwyn Scally (University of Cambridge) summarized that parental age remains the primary driver of DNM rates, while ancestry and environmental factors such as smoking can leave a small imprint. Dr Raheleh Rahbari and Dr Hilary Martin (Wellcome Sanger Institute) added that these findings broaden our understanding of how new genetic variation arises and that larger, more detailed studies of environmental exposure could reveal additional contributors to germline mutation variability.
Funding
This work was supported by the National Institute for Health Research and NHS England through the National Genomic Research Library, with additional funding from Wellcome, Cancer Research UK and the Medical Research Council. Full acknowledgements and detailed funding statements are provided in the original publication.
About this genetics research news
Author: Communications Team, Wellcome Sanger Institute
Source: Wellcome Sanger Institute communications
Contact: Communications Team, Wellcome Sanger Institute
Image credit: Neuroscience News
Original research (open access): “The impact of ancestral, genetic, and environmental influences on germline DNM rates and spectra” by Garcia-Salinas, O. I. et al., published in Nature Communications. The study uses a genetically diverse set of approximately 10,000 whole-genome sequenced trios to explore how ancestry, genetics and environmental factors shape germline mutation rates and spectra.
Abstract (summary)
De novo germline mutation influences genetic diversity and disease risk. Using nearly 10,000 sequenced parent–child trios, the authors report modest but significant differences in germline DNM rates and mutation spectra across continental ancestry groups that may reflect genetic or environmental correlates. Epidemiological analysis links parental cigarette smoking to a higher DNM rate, though smoking does not explain the ancestry-associated differences. Mendelian randomisation analyses of several other potential mutagens show no clear consistent effects, except for a relationship between later age at menopause and reduced DNM rate. Overall, this work clarifies factors that influence when and how new germline mutations arise.